APA (7th ed.) Citation

Powis, K. M., Powis, K. M., Powis, K. M., Jao, J., Jao, J., Jao, J., . . . Serghides, L. (2025). Growth-promoting hormonal alterations in pregnant women living with HIV receiving dolutegravir-based antiretroviral treatment are associated with lower infant 1-year weight z-scores. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Powis, Kathleen M., et al. Growth-promoting Hormonal Alterations in Pregnant Women Living with HIV Receiving Dolutegravir-based Antiretroviral Treatment Are Associated with Lower Infant 1-year Weight Z-scores. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Powis, Kathleen M., et al. Growth-promoting Hormonal Alterations in Pregnant Women Living with HIV Receiving Dolutegravir-based Antiretroviral Treatment Are Associated with Lower Infant 1-year Weight Z-scores. Frontiers Media S.A, 2025.